OBJECTIVE: Adipose tissue is now considered as an endocrine and secretory organ, and some adipocyte factors are thought to play a major role in the induction of insulin resistance in skeletal muscle. Here we tested the hypothesis that the crosstalk between fat and muscle involves activation of inhibitor kB Kinase (IKK) in the myocytes. MEASUREMENTS: Adipocyte-conditioned culture medium was added to the muscle cells overnight, or human fat and muscle cells were kept in co-culture. Insulin signalling was subsequently analysed in the myocytes. Involvement of IKK was assessed using I229, a highly specific inhibitor of the IKK complex. RESULTS: Adipocyte-conditioned medium strongly inhibited insulin-induced serine phosphorylation of Akt in myocytes with a rapid parallel activation of the nuclear factor kB pathway in these cells. Conditioned medium lacking the perturbation of insulin signalling did not activate NF-kB. Insulin signalling to Akt was completely abrogated under co-culture conditions. The IKK inhibitor I229 did not affect protein expression of Akt, but fully restored insulin action in myocytes subjected to co-culture. CONCLUSION: These data show that the release of fat cell factors may rapidly induce insulin resistance in human skeletal muscle cells. This process appears to be mediated by an IKK/NF-kB dependent pathway. We suggest that inhibitors of IKK would be of use to counteract the negative crosstalk between fat and muscle.
Introduction
A key feature of type II diabetes observed very early in the prediabetic state is disturbance of insulin signalling in skeletal muscle initiating insulin resistance.
1,2 One of the major risk factors for the development of type II diabetes is represented by obesity, which is almost invariably associated with insulin resistance. 3 Goodpaster et al 4 could show that in obesity, adipose tissue is dispersed within muscle and that this strongly correlated to muscle insulin resistance. It is well established that adipose tissue represents a major secretory and endocrine active organ producing a variety of factors that potentially mediate skeletal muscle insulin resistance. 5 To assess the role of adipocyte secreted factors in the development of muscle insulin resistance we recently established a novel system of coculture of human fat and muscle cells. Our results showed rapid impairment of insulin signalling in skeletal muscle cells subjected to co-culture 6 confirming the paracrine crosstalk between fat and muscle and emphasizing the role of adipocytes in the development of muscle insulin resistance. It is well known that many adipocyte secreted factors, which lead to insulin resistance in different models of obesity, for example tumor necrosis factor a (TNFa) or free fatty acids, are able to increase the serine and threonine phosphorylation of IRS-1.
7,8 Furthermore, we reported on an increased serine/ threonine phosphorylation of IRS-1 in insulin-resistant cardiomyocytes of obese Zucker rats. 9 Thus, the serine and threonine phosphorylation of IRS-1 seems to represent a critical step in the development of insulin resistance. Interestingly, salicylates are able to decrease the serine and threonine phosphorylation and enhance the tyrosine phosphorylation of IRS-1 in obese Zucker rats. 10 Furthermore, insulin resistance induced by lipid infusion could also be ameliorated by salicylates. 11 Salicylates like aspirin act as inhibitor kB Kinase (IKK) inhibitors, leading to the hypothesis that this kinase might mediate serine and threonine phosphorylation of IRS-1. 10 This was recently confirmed by the data of Gao et al, 12 showing that IRS-1 is a novel direct substrate for IKK and that phosphorylation by IKK contributes to insulin resistance. This supports the notion of a crosstalk between metabolic and inflammatory signalling pathways, since IKK and its downstream effector nuclear factor kB (NF-kB) are closely associated with inflammation. 13, 14 Clinical data suggest that all major components of the metabolic syndrome including obesity are associated with low-grade systemic inflammation (for review see Das 15 ). However, it is not known if the paracrine interaction between fat and muscle may directly elicit an inflammatory response in the muscle cell. In the present investigation we have taken advantage of our recently described co-culture model of human fat and muscle cells 6 to address this question. The results show that presently unknown fat cell factors rapidly activate the IKK/NF-kB pathway in the myocytes inducing impaired insulin signalling.
Material and methods

Material
Reagents for SDS-PAGE were supplied by Amersham Pharmacia Biotech (Braunschweig, Germany) and by Sigma (München, Germany). Bovine serum albumin (BSA, fraction V, fatty acid free) was obtained from Boehringer (Mannheim, Germany) and human recombinant TNF-a was from Sigma. Recombinant human resistin was provided by PreproTech (London, UK). The IKK-inhibitor I229 was from Aventis (Frankfurt, Germany). I229 has submicromolar activity on the isolated IKK complex and is highly specific on IKK. Its general structure is described in PCT/EP00/05340. Polyclonal antibodies antiphospho-Akt (Ser473), anti-Akt, antiphospho-NF-kB (P65) and anti-NF-kB (P65) were supplied by Cell Signaling Technology (Frankfurt, Germany). HRP-conjugated goat-anti-rabbit IgG antibody was from Promega (Mannheim, Germany). Collagenase CLS type 1 was obtained from Worthington (Freehold, NJ, USA) and culture media were obtained from Gibco (Berlin, Germany). Primary human skeletal muscle cells and supplement pack for growth medium were obtained from PromoCell (Heidelberg, Germany). Sterile plasticware for tissue culture was purchased from FALCON (Becton Dickinson, Heidelberg, Germany). Membrane inserts for six-well culture dishes with a pore size of 0.4 mm (pore density 1.6 Â 10 6 /cm 2 ) and insert companion plates were supplied by FALCON. All other chemicals were of the highest analytical grade commercially available and were purchased from Sigma.
Culture of human skeletal muscle cells Satellite cells were isolated from M. rectus abdominis by enzymatic digestion with trypsin followed by a purification step with fibroblast-specific magnetic beads to prevent contamination with fibroblasts. After two passages, the myoblasts are characterized by the manufacturer (PromoCell) using immunohistochemical detection of sarcomeric myosin in differentiated cultures at 100% confluence (8 days ) or in a sixwell culture dish, and kept in culture for 16 h. After washing, culture was continued in an adipocyte differentiation medium, as detailed previously. 16 After a period of 15 days, 60-80% of seeded preadipocytes developed to differentiated adipose cells, as defined by cytoplasm completely filled with small or large lipid droplets. These cells were then used for the co-culture experiments and for generation of adipocyteconditioned medium. Preliminary data in our laboratory have shown a similar hormonal control of adipose differentiation in preadipose cells from mammary adipose tissue and the subcutaneous abdominal depot. Further, the release of leptin and plasminogen activator inhibitor 1 (PAI-1) from both depots was found to be comparable.
Co-culture
Co-culture of human fat and muscle cells was conducted according to our recently published protocol. 6 Briefly, after in vitro differentiation of preadipocytes on membrane inserts, the adipocytes were washed once with PBS and then incubated for 24 h in skeletal muscle cell differentiation medium containing 1 pM insulin. Thereafter, adipocytes were washed twice with PBS and individual membrane inserts were subsequently transferred to the culture plates containing differentiated (4 days) myocytes in a-modified
Eagle's medium containing 1 pM insulin. This resulted in an assembly of the two cell types sharing the culture medium but being separated by the membrane of the insert. Distance from the bottom of the culture dish to the membrane was 0.9 mm. Co-culture was conducted for 48 h. Integrity of both cell types was routinely checked by light microscopy at the end of the co-culture period.
Concentration of adipocyte supernatant
Fully differentiated adipocytes were incubated for 48 h in amodified Eagle's medium containing 1 pM insulin. After that time, the cell culture supernatants were collected and were concentrated using Vivaspin Columns (Sartorius, Goettingen, Germany).
Immunoblotting
Muscle cells were treated as indicated and lysed in a buffer containing 50 mM Tris/HCl (pH 7.4), 1% (vol/vol) NP-40, 0.25% (vol/vol) sodium-deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM Na 3 VO 4 and protease inhibitor cocktail. After incubation for 2 h at 41C the suspension was centrifuged at 10 000 Â g for 10 min. Thereafter, total cell lysates were separated by SDS-PAGE using gradient (8-18%) horizontal gels and transferred to polyvinylidene fluoride (PVDF) filters in a semidry blotting apparatus. 17 For detection of p-Akt, Akt, p-P65 or P65, filters were blocked with Tris-buffered saline (TBS) containing 0.1% Tween-20 and 5% non-fat dry milk, and subsequently incubated over night with a 1 : 1000 dilution of appropriate antibodies. After extensive washing, filters were incubated with goat-anti-rabbit HRP coupled antibody and processed for enhanced chemiluminescene (ECL) detection using SuperSignal Substrate (Pierce, Rockford, IL, USA). Signals were visualized and evaluated on a LUMI Imager work station using image analysis software (Boehringer Mannheim, Mannheim, Germany).
Presentation of data and statistics
Statistical analysis was carried out by using either Student's t-test or analysis of variance test (ANOVA) for comparison of more than two variables. All statistical analyses were carried out using Prism software (Graphpad, San Diego, CA, USA). A P-value of less than 0.05 was considered to be statistically significant. Corresponding significance levels are indicated in the figures.
Results
Adipocyte-conditioned medium impairs insulin signalling in skeletal muscle cells Our observations in the co-culture model of fat and muscle cells indicated that adipocyte secreted factors may rapidly impair insulin signalling in the myocytes. 6 To investigate whether the resistance-inducing factors are independently secreted by adipocytes or if a crosstalk between muscle and fat cells is required to initiate secretion of these factors, adipocytes were cultured for 48 h using exactly the same protocol as described for the co-culture followed by collection of the medium. This material was lyophilized, reconstituted and finally added to myotubes from four different muscle cell donors. As a control we used lyophilized adipocyte medium. After 16 h, acute insulin signalling in the muscle cells was assessed at the level of the serine/ threonine kinase Akt, a central component of downstream insulin signalling to glucose transport and glycogen synthesis. 18 Using this approach (Figure 1 ) we found a highly significant inhibition of insulin signalling comparable to our earlier results obtained with the co-culture. 6 It is worth noting that basal phosphorylation of Akt was not significantly altered under these conditions. Figure 2 (upper panel) illustrates the fat cell donor-specific potency of adipocyteconditioned medium in reducing insulin signalling. As can be seen from the data, fat cells from three out of five donors produced more than 60% inhibition of insulin-stimulated Akt phosphorylation in skeletal muscle cells. On the other hand, the data show that this is not a general property of adipocytes since fat cells from two out five donors did not significantly modify insulin signalling in the myocytes (Figure 2, upper panel) . However, this is unrelated to the BMI of the fat cell donors ( Figure 2 ). As expected, a comparable variation in the sensitivity of muscle cell donors was also observed (Figure 2 , lower panel) with an inhibition of insulin signalling ranging between 20 and 65%. Both TNF-a and resistin are released at very low concentrations (0.02 and 0.3 pmol/l, respectively) by cultured human mammary adipocytes, 6 and only very high doses of TNF-a were found to impair insulin signalling in skeletal muscle cells. 6 As shown in Figure 3 , resistin failed to modify insulin signalling in the myocytes even at 1 mg/ml (51 nmol/ l). IL-6 is released at much higher concentrations (20-30 pmol/l) by human adipocytes. 19 However, only at 10 nmol/l IL-6 produced a slight (20%) inhibition of insulin-stimulated Akt phosphorylation (Figure 3b) . Further, high doses of IL-1, angiotensin II and fatty acids were unable to modify insulin signalling (data not shown).
Adipocyte-conditioned medium activates NF-jB in skeletal muscle cells To gain more insight into the mechanism of the paracrine crosstalk between fat and muscle and to assess the potential involvement of inflammatory signalling, we used I229, a highly specific inhibitor of the IKK complex. As shown in Figure 4 , TNF-a produced a rapid and prominent serine phosphorylation of the p65 subunit of NF-kB, reflecting strong activation of this pathway by the cytokine. This activation was nearly completely abrogated by preincubation with the IKK-inhibitor I229, confirming bioactivity of this compound in human skeletal muscle cells (Figure 4) . We then addressed the question if adipocyte-conditioned medium is able to activate the NF-kB pathway in skeletal muscle
Skeletal muscle insulin resistance D Dietze et al cells. As shown in Figure 5 , after a 10-min stimulation period no phosphorylation of P65 could be observed in the myocytes. Preincubation with I229 significantly lowered the basal phosphorylation of P65. After incubation of myocytes with conditioned medium for 30 min a two-fold activation of P65 serine phosphorylation was observed, with I229 preventing this effect. These findings were consistent in three skeletal muscle cell donors each. As outlined above (see Figure 2) , the different fat cell donors exhibited a remarkable difference in the potency to induce insulin resistance. We therefore compared the NF-kB activation in the myocytes by conditioned medium 3 (CM3) and CM4. The latter was found to be unable to modify insulin signalling (see Figure 2 ). As presented in Figure 6 , this correlated with the inability of CM4 to activate NF-kB in the myocytes. These observations suggest an important role of inflammatory signalling in the induction of skeletal muscle insulin resistance.
Inhibition of NF-jB activation during co-culture of fat and musle cells prevents impairment of insulin signalling
To substantiate the role of the IKK/NF-kB pathway in the development of insulin resistance, we tested the IKK- Quanitifcation of immunoblots was performed as described in Figure 1 . All data were normalized to P65 protein expression and are expressed relative to the control value. Data are mean values7s.e. of six independent experiments using three different muscle cell donors (M5: n ¼ 2; M9: n ¼ 2; F10: n ¼ 2). Skeletal muscle insulin resistance D Dietze et al inhibitor I229 under co-culture conditions. Human skeletal muscle cells were co-cultured with human adipocytes for 48 h in the absence or presence of I229, and acute insulin signalling was then determined. Direct addition of I229 to the skeletal muscle cells appeared to increase the insulininduced serine phosphorylation of Akt kinase without affecting the expression level of this enzyme ( Figure 7) ; however, this did not reach statistical significance. As presented in Figure 7 , insulin signalling to Akt was completely blocked in skeletal muscle cells subjected to coculture conditions consistent with our earlier report. 6 Addition of I229 to the co-culture completely prevented this effect and restored normal insulin action.
Discussion
Increasing evidence indicates that insulin resistance, obesity and other components of the metabolic syndrome are associated with low-grade inflammation. 15, 20, 21 This is based on the observation that inflammatory markers like Creactive protein (CRP), plasminogen activator inhibitor-1 (PAI-1) and IL-6 are significantly increased in insulinresistant people and are predictors of the development of type II diabetes. 22, 23 Obesity contributes to a proinflammatory milieu 24 and it has now been recognized that adipose tissue functions as an endocrine organ, which secretes multiple proinflammatory molecules. 25 Using our co-culture model of human fat and skeletal muscle cells, 6 we show here that the paracrine interaction between fat and muscle involves the activation of the IKK/NF-kB pathway in the muscle cell, finally resulting in impaired insulin signalling. This is consistent with the view that the crosstalk between inflammatory and metabolic signalling pathways may elicit insulin resistance and extends this concept to human skeletal muscle. Adipocyte-conditioned medium generates impairment of insulin signalling in the myocytes comparable to our earlier results obtained in the co-culture. 6 However, a prominent interindividual variation was observed. This cannot be explained by metabolic differences of the fat cell donors since the cells are differentiated and kept in culture for more than 2 weeks. Further, all donors were healthy with near normal BMI. It may therefore be speculated that genetic factors determine the differential release of insulin resistance-inducing adipokines by normal adipocytes. Our data also show interindividual variation between different muscle cell donors, emphasizing the complexity of the crosstalk between fat and muscle under in vivo conditions. The identity of released adipokines remains currently unknown. TNFa and resistin are produced at very low concentrations by in vitro differentiated adipocytes. 6 Further, more recent studies do not support a role for resistin in human insulin resistance. 26, 27 Direct addition of resistin, IL-1, angiotensin and fatty acids to human skeletal muscle cells did not compromise insulin signalling to Akt. Human adipocytes have been shown to secrete a substantial amount of IL-6, 19 however, even extremely high doses of this cytokine produced only a marginal impairment of insulin signalling. Additional work is currently under way to identify the factors mediating skeletal muscle insulin resistance. Recent studies have shown that factors that seem to be implicated in the development of insulin resistance are activators of IKK and its downstream effector NF-kB. 28, 29 These factors include adipocytokines like TNFa 30 and free fatty acids. 31 Our results suggest that activation of the IKK/NF-kB pathway is of central importance for initiating skeletal muscle insulin resistance in humans since (i) TNFa was found to induce a prominent activation of NF-kB in human skeletal myotubes and abrogates insulin signalling in these cells when added at high doses; 6 (ii) adipocyteconditioned medium impaired insulin signalling and was able to activate NF-kB; (iii) inactive adipocyte supernatants do not activate NFkB and (iv) co-culture induced insulin resistance was ameliorated by addition of a selective Skeletal muscle insulin resistance D Dietze et al inhbitor of IKK. TNFa has been consistently reported to increase the serine phosphorylation of IRS-1 resulting in perturbation of insulin signaling. 7, 32 Very recent data show that this process involves multiple serine/threonine kinases in addition to IKK, including c-Jun NH 2 -terminal kinase (JNK), Akt/PKB, PKCz, extracellular signal-regulated kinase (ERK) and mammalian target for rapamycin (mTOR). 33 A similar complex network of multiple kinases may also be operative in the paracrine crosstalk between fat and muscle; however, IKK may function as a critical upstream regulator since the highly selective IKK-inhibitor completely prevented impairment of insulin signalling and restored normal insulin action. It must be mentioned, however, that the molecular mechanisms mediating the crosstalk between NF-kB activation and insulin signalling in human skeletal muscle cells remain unknown. In addition to serine and threonine phosphorylation of IRS-1 by IKK, 12 an altered expression profile of NF-kB dependent genes might also be involved. Further work will be needed to dissect these pathways and to define the downstream targets of IKK that lead to perturbation of the insulin signalling cascade.
Our current results using the IKK-inhibitor I229 in the co-culture model exhibit a certain similarity to our earlier observations on the thiazolidinedione troglitazone, 6 which was found to sensitize the skeletal muscle cells and completely prevented insulin resistance. The IKK-inhibitor did not sensitize the myocytes but restored normal insulin signalling. I229 is a benzimidazole derivative, which showed an IC 50 value of 1.9 nM against the IKK complex. Interestingly, in a very recent report it was shown that troglitazone selectively blocks NF-kB-dependent repression of multiple adipocyte-specific genes, 34 suggesting that inhibition of NF-kB activity is a mechanism by which PPARg ligands improve insulin sensitivity. These data additionally support the view that activation of the IKK/NF-kB pathway is of central importance in the pathogenesis of insulin resistance. It should be noted that in the present study the IKK inhibitor I229 was used at 10 mM, whereas aspirin was used at a 1000-fold higher concentration both in vivo 11 and in vitro. 33 Recent data show that under these conditions aspirin is not selective for IKK and that the protection of IRS proteins from serine phosphorylation is due to the inhibition of multiple kinases. 33 However, our results reinforce the concept that NF-kB is a potential therapeutic target for obesity-linked type II diabetes and that the future development of highly selective IKK inhibitors will provide a new approach for the prevention of insulin resistance. In summary, our data show that adipokines lead to a rapid disturbance of insulin signal transduction in human skeletal muscle cells in vitro. We suggest that a presently unknown array of adipocyte factors generates this muscle insulin resistance. The IKK/NF-kB pathway seems to play a pivotal role in the paracrine crosstalk between fat and muscle and may be useful for therapeutic intervention.
